Collegium Pharma Files 2024 Proxy Statement
Ticker: COLL · Form: DEF 14A · Filed: Mar 28, 2025 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | DEF 14A |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, board-of-directors
Related Tickers: COLL
TL;DR
Proxy filing out for Collegium Pharma (COLL) - exec comp & board details.
AI Summary
Collegium Pharmaceutical, Inc. filed its DEF 14A on March 28, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and board member information, including Vikram Karnani, who was granted employee stock options. The company's principal executive offices are located at 100 Technology Center Drive, Stoughton, MA.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and board nominations, enabling informed voting decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information to shareholders and does not inherently indicate new risks.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for compensation and board information.)
- 20250328 — Filing Date (Date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- COLLEGIUM PHARMACEUTICAL, INC (company) — Filer
- Vikram Karnani (person) — Board Member / Executive
- 100 Technology Center Drive, Stoughton, MA (location) — Company Address
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
Who are the key individuals mentioned in relation to compensation or board roles?
Vikram Karnani is mentioned in relation to board membership and employee stock options.
When is the company's fiscal year end?
The company's fiscal year ends on December 31st.
What is the company's primary business classification?
The company is classified under Pharmaceutical Preparations [2834].
Where is Collegium Pharmaceutical, Inc. headquartered?
The company's business and mail address is 100 Technology Center Drive, Stoughton, MA 02072.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 28, 2025 by Vikram Karnani regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).